DBV's medical officer explains why he's bullish that the allergy patch for peanut will finally get approved. Also in the works: a milk patch.| Allergic Living
The FDA approves Palforzia OIT for toddlers aged 1 to 3 with peanut allergy. In study, 74% on therapy could tolerate equivalent of 2 peanuts.| Allergic Living
FDA approves Xolair for food allergies. The anti-IgE shot can treat multiple food allergies and can keep reactions from becoming anaphylaxis.| Allergic Living
Wearing DBV's novel peanut allergy patch for 2 years instead of 1 year led to a significant increase in the number of kids desensitized.| Allergic Living
Viaskin Peanut patch shows strong results in desensitizing allergic toddlers. We speak to the lead author about why younger can work best.| Allergic Living
After using the Viaskin patch for 3 years, 52% of peanut-allergic kids aged 4-11 could tolerate at least 1,000 milligrams of peanut protein.| Allergic Living
A study of children undergoing milk allergy OIT finds allergic reactions are common, with 16 percent being classified as anaphylactic.| Allergic Living
The future of the peanut patch immunotherapy treatment is uncertain after a Phase 3 trial failed to meet its main statistical goal.| Allergic Living
FARE is taking on American Airlines for refusing to allow those with food allergies to pre-board flights to wipe down seating areas.| Allergic Living
Shelley Case on "gluten-removed" beers vs. gluten-free beer, and why it's important for those with celiac disease to know the difference.| Allergic Living
Allergies to peanut are one of the most common and severe types of food allergies.| Allergic Living
With the peanut allergy patch for children, duration matters. Kids in a Phase 3 trial for 5 years had better tolerance, and no safety issues.| Allergic Living
The FDA has declined approval of neffy, the needle-free epinephrine nasal spray, calling for more study. Allergy families are disappointed.| Allergic Living
An expert panel votes to recommend FDA approval of ARS Pharma's neffy epinephrine nasal spray, as families speak of needle fears.| Allergic Living
Inside the strange contrast of Jack Fowler's call for nut allergy accommodation, while ad agency promotes Snickers as the top airline snack.| Allergic Living